News

Modella AI and AstraZeneca link for cancer clinical development
By integrating foundation models into its R&D pipeline, AstraZeneca seeks to enable data-driven discovery methods.
AstraZeneca rises Friday, outperforms market
AstraZeneca PLC closed 22.80% short of its 52-week high of £133.88, which the company reached on September 3rd.
Why AstraZeneca Stock Got Thumped on Thursday
A cautious market traded AstraZeneca stock down by more than 2% following the report, on a day when the S&P 500 index landed ...
AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer
The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.
AstraZeneca considers moving listing to US, the Times reports
AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...
AstraZeneca CEO Wants to Move Listing to US, Times Reports
AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...
AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment
AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ...
FTSE 100 movers: AstraZeneca gains; Barratt hit by MJ Gleeson update
London’s FTSE 100 was flat at 8,824.61 in quiet afternoon trade on Friday, with US markets closed for Independence Day.